Team announcement

Pancreatic Cancer Action Network Appoints New Board Chair and Members

Pancreatic Cancer Action Network Appoints New Board Chair and Members, Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network (PanCAN) has announced the appointments of Hilarie Koplow-McAdams as Board Chair and Karen Young as Vice Chair and also welcomed Dennis Cronin and Nancy Stagliano as new members. This new strategic leadership team at PanCAN is hoped to accelerate progress for pancreatic cancer patients by pushing innovation within the field.

The Board at PanCAN is composed of a team of highly dedicated and experienced individuals. Each has been carefully selected based on their integral expertise across their communities, business, higher education, fundraising, policy, legal issues, finance, and board governance. Every member has been personally affected by pancreatic cancer and is able to empathize with patients and put their needs at the forefront of their work.

Hilarie Koplow-McAdams, recently appointed Chair and previous Vice Chair at PanCAN, is a veteran of the enterprise software space. She's currently working as a Venture Partner at New Enterprise Associates and has been a leader at companies, including Salesforce, Intuit, and Oracle. She has been an active member of PanCAN's Board of Directors for four years and dedicates her work there to her father, who died from pancreatic cancer in 2012, less than two years following the diagnosis.

Taking the Vice Chair position is Karen Young, who has been a board member for two years, bringing 23 years' professional experience with her. Ms. Young was touched by pancreatic cancer after the loss of both her father and aunt to the disease. With a background in life sciences, she is currently working as PwC's U.S. Pharmaceutical and Life Sciences Leader, where she is responsible for supervising over 3,000 professionals in delivering advisory, tax and assurance services.

"We are so lucky to have two strong and strategic female executives serving as key leaders on PanCAN's board of directors," said Julie Fleshman, JD, MBA, president and CEO of PanCAN. "They will help PanCAN navigate to our next level of growth as we strive to reach new, ambitious goals and dramatically improve patient outcomes."

Dennis Cronin is himself a 10-year pancreatic cancer survivor and has previously served as a member of PanCAN's Survivor Council for four years. At present, he is the Senior Vice President Treasury Service and Chief Risk Officer and Highmark Health in Pittsburgh.

Nancy Stagliano, Ph.D., has been CEO of Neuron23, where she is currently standing as Executive Chair. Pancreatic cancer has been a large part of her life, also as her mother passed away from the disease. She is a highly successful serial biotechnology entrepreneur, working for various private and public biotechnology boards and is extremely passionate about supporting PanCAN in their work.

"Nancy's incredible expertise in the biotechnology field and Dennis' background in risk management provide additional expertise to an extremely talented group of board members," Fleshman said. "I am grateful to all of our board members for their incredible support and the advice they provide to the organization."

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.